Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by JAKPUG4LIFEon Oct 28, 2020 10:24am
89 Views
Post# 31795103

RE:RE:PUMP....PUMP.....PUMP

RE:RE:PUMP....PUMP.....PUMPI'm sure FSD IR can give you all the answers you need. They have in the past, No. LoL.
Bigmac4000 wrote: Anyone look at the stock today. Hit $2.21 cents or $.0109 a share. By next week it will be under a penny. On the Nasdaq they are 65 cents away from delisting or RS. They don't really have enough diluted shares to safely RS with any insurance. At 20+ mill shares that's not going to give them much of a safety net since they drop 10-15 cents a day. They refuse to tell us when they will start the phase 2a trials. I can't find it on any websites on FDA site. Not covid testing or non covid. So why the media posting about FDA permission to start trials Oct 01 if they don't pan to start trials. Could it be a stall tactic to get more out of FSD before folding or is there another reason to not start asap? No funds? Not enough people in hospital willing to try microPEA since other medications are working and deaths are dropping? I'm not bashing I'm asking. Please fill me in as to why it has not started or please lead me to factual proof it has started.
Mil_Man54 wrote: Look at that....another pumper account created today, Billionairemind....telling us how great FSD is.....I'm shocked....I think that makes it over 400 new accounts pumping this dumpster fire....desperatiion doesn't even come close to capturing what these guys are feeling.




Bullboard Posts